Integral Ad Science (IAS) Projected to Post Earnings on Thursday

Key Points

• Integral Ad Science is expected to release its Q2 2025 earnings report on August 7th, with analysts predicting earnings of $0.04 per share and revenue of $143.02 million.
• In the last financial quarter, the company reported earnings of $0.05 per share, exceeding analysts' expectations, and a revenue of $134.07 million, above the anticipated $129.20 million.
• Analysts have mixed ratings for IAS, with six issuing a hold and seven a buy, and the average target price currently stands at $13.65.

Integral Ad Science (NASDAQ:IAS - Get Free Report) is anticipated to announce its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $143.02 million for the quarter. Integral Ad Science has set its Q2 2025 guidance at EPS and its FY 2025 guidance at EPS.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.02. Integral Ad Science had a net margin of 8.56% and a return on equity of 4.74%. The company had revenue of $134.07 million for the quarter, compared to analysts' expectations of $129.20 million. On average, analysts expect Integral Ad Science to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Integral Ad Science Stock Performance

NASDAQ IAS traded down $0.34 on Friday, hitting $7.86. 1,098,228 shares of the stock traded hands, compared to its average volume of 709,102. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 1.40 and a beta of 1.57. The business's fifty day moving average is $8.18 and its two-hundred day moving average is $8.61. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.01 and a current ratio of 4.01. Integral Ad Science has a 12 month low of $6.26 and a 12 month high of $13.62.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on IAS. Wall Street Zen upgraded Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Saturday, June 14th. Barclays increased their target price on shares of Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 13th. Morgan Stanley lowered their price target on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Raymond James Financial upped their price target on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a research note on Tuesday, May 13th. Finally, Stifel Nicolaus lifted their price objective on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $13.65.

Insider Buying and Selling at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 14,904 shares of the business's stock in a transaction dated Tuesday, July 8th. The stock was sold at an average price of $8.31, for a total transaction of $123,852.24. Following the completion of the transaction, the chief executive officer directly owned 379,316 shares in the company, valued at $3,152,115.96. The trade was a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold a total of 33,518 shares of company stock valued at $270,739 over the last quarter. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of Integral Ad Science

A number of large investors have recently modified their holdings of IAS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Integral Ad Science by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,326 shares of the company's stock worth $349,000 after purchasing an additional 1,807 shares in the last quarter. Caxton Associates LLP purchased a new stake in Integral Ad Science in the first quarter worth approximately $282,000. Royal Bank of Canada grew its position in Integral Ad Science by 219.6% during the first quarter. Royal Bank of Canada now owns 55,941 shares of the company's stock valued at $451,000 after acquiring an additional 38,439 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of Integral Ad Science during the first quarter worth approximately $1,986,000. Institutional investors own 95.78% of the company's stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.